Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Anika Therapeutics (NQ: ANIK ) 24.27 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Anika Therapeutics < Previous 1 2 Next > Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 09, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 15, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Sidoti Events, LLC's Virtual August Micro-Cap Conference August 13, 2024 Via ACCESSWIRE Anika to Participate in the Sidoti Virtual Investor Conference August 05, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024 July 25, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 16, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs July 11, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 07, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika Enters into Cooperation Agreement with Caligan Partners May 28, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 03, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024 April 18, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference April 02, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 08, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024 February 27, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting February 13, 2024 From Anika Therapeutics Inc. Via GlobeNewswire Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release November 28, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika to Participate in Upcoming Investor Conferences November 07, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023 October 10, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting September 19, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 15, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika to Participate in the Sidoti Small Cap Virtual Investor Conference September 12, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs August 17, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023 July 20, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting July 12, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone May 30, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023 April 19, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika Enters Into Cooperation Agreement with Caligan Partners April 13, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference April 12, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA April 03, 2023 From Anika Therapeutics Inc. Via GlobeNewswire Anika Files Preliminary Proxy Statement March 27, 2023 From Anika Therapeutics Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.